Falsified and substandard antimalarial medicines pose an immediate danger to vulnerable populations and could increase the threat of malaria drug resistance emerging and spreading. The major challenge in preventing the spread and distribution of poor quality medicines is the lack of accessible and reliable information on prevalence of poor quality medicines.
The WWARN Antimalarial Quality (AQ) Surveyor helps to respond to some of the critical gaps in information. This mapping tool delivers customised summaries of published reports of antimalarial medicine quality across regions and over time.
Find out more about WWARN’s activities in the area of Drug Quality.
For more information about contributing antimalarial quality data to WWARN or helping us to improve the AQ Surveyor, please email aq [at] wwarn [dot] org (aq(at)wwarn.org).